Efficacy of eculizumab in transplantation-associated thrombotic microangiopathy: results of the French nationwide study on behalf of the SFGM-TC and the CNR-MAT
Bone Marrow Transplant. 2024 Apr 11.
doi: 10.1038/s41409-024-02279-2.
Online ahead of print.
1 Hematology Department, Saint-Antoine Hospital, APHP, Paris, France.
2 Hematology Transplant Unit - French Reference Center for Aplastic Anemia, Saint Louis Hospital, APHP, Paris, France. Flore.sicre-de-fontbrune@aphp.fr.
3 Hematology Department, Besançon University Hospital, Besançon, France.
4 Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital, APHP, Paris, France.
5 Hematology Department, Nancy University Hospital, Vandoeuvre-lès-Nancy, France.
6 Hematology Department, Necker Hospital, APHP, Paris, France.
7 Hematology Department, Grenoble University Hospital, Grenoble, France.
8 Hematology Department, Montpellier University Hospital, Montpellier, France.
9 Nice University Hospital, Nice, France.
10 Hematology Department, Lille University Hospital, Lille, France.
11 Hematology Department, Caen University Hospital, Caen, France.
12 Hematology Department, Pitié-Salpêtrière Hospital, APHP, Paris, France.
13 Hematology Transplant Unit - French Reference Center for Aplastic Anemia, Saint Louis Hospital, APHP, Paris, France.
14 Hematology Department, Saint-Antoine Hospital, APHP, Paris, France. paul.coppo@aphp.fr.
15 French Reference Center for Thrombotic Microangiopathies, Paris, France. paul.coppo@aphp.fr.
16 INSERM UMRS1138, Centre de Recherche des Cordeliers, Paris, France. paul.coppo@aphp.fr.